97 results on '"KASPRZYK, PHILIP G."'
Search Results
2. Safety of a Sustainably Produced, Bioengineered, Nature-Identical Salidroside Compound
3. Recombinant Anti-ErbB2 Immunotoxins Containing Pseudomonas Exotoxin
4. A Mitogenic Peptide Amide Encoded within the E Peptide Domain of the Insulin-Like Growth Factor IB Prohormone
5. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
6. Pseudopeptide farnesyl-protein transferase inhibitors containing 5,5-dimethylthiazolidine-4-carboxylic acid
7. IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells
8. Preclinical testing of an anti-erbB-2 recombinant toxin
9. Homocamptothecins: E-Ring Modified CPT Analogues
10. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
11. Autocrine Growth Factors and Lung Cancer
12. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
13. Autocrine Growth Factors and Lung Cancer
14. Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines
15. Cover Picture: Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors (ChemMedChem 1/2014)
16. STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice
17. Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors
18. Targeted Cytotoxic Somatostatin Conjugates Specifically Inhibit the Growth of SCLC
19. Novel Camptothecin Somatostatin Conjugate in Treatment of Tumor Cells Expressing sst2 Receptors
20. Abstract 2795: Safety profile and therapeutic potential in breast cancer of STX140, an original tubulin binding agent
21. Abstract 756: Optimization of tetrahydroisoquinoline-based microtubule disruptors as anticancer agents
22. IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents
23. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
24. AR36A36.11.1, a monoclonal antibody targeting CD59, enhances complement activity and exhibits potent in vivo efficacy in multiple human cancer models
25. 3,17-Disubstituted 2-Alkylestra-1,3,5(10)-trien-3-ol Derivatives: Synthesis, In Vitro and In Vivo Anticancer Activity
26. Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein Complex
27. Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
28. Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval
29. BN80927
30. A Novel Synthetic Inhibitor of CDC25 Phosphatases
31. The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison
32. Tetrahydroisoquinolinone-Based Steroidomimetic and Chimeric Microtubule Disruptors.
33. Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
34. Effect of gastrin‐releasing peptide on the pancreatic tumor cell line (capan)
35. 2-MeOE2 bisMATE and 2-EtE2 bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
36. Preclinical Evaluation of an Anti-Autocrine Growth Factor Monoclonal Antibody for Treatment of Patients With Small-Cell Lung Cancer.
37. Growth Factor Effects on Small Cell Lung Cancer Cells Using a Colorimetric Assay: Can a Transferrin-Like Factor Mediate Autocrine Growth?
38. Consideration of the Chemistry of Solid-Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptidesa,b.
39. Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval
40. Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation
41. Autocrine Growth Factors as Therapeutic Targets in Lung Cancer
42. Mass Spectrometric Identification and Sequencing of Novel Neuropeptides.
43. In vivo diagnosis and therapy of human tumors with monoclonal antibodies: Selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung
44. Growth Factor Effects on Small Cell Lung Cancer Cells Using a Colorimetric Assay: Can a Transferrin-Like Factor Mediate Autocrine Growth?
45. Fluorescence energy transfer experiments with Escherichia coli carbamoyl-phosphate synthetase
46. Consideration of the Chemistry of Solid‐Phase Matrix Interactions Leads to Improved Quantitation of Neuropeptidesa,b
47. Chapter 19 Some considerations for the therapeutic use of monoclonal antibodies in lung cancer
48. Posttranslational Processing of Endogenous and of Baculovirus-Expressed Human Gastrin-Releasing Peptide Precursor
49. Distances between active site probes in glutamine synthetase from Escherichia coli: fluorescence energy transfer in free and in stacked dodecamers
50. Spatial relationships among the active and allosteric sites of carbamoyl-phosphate synthetase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.